Bhringraj (Eclipta prostrata, accepted name; synonym Eclipta alba) is a small herb of the Asteraceae family used for centuries in Ayurvedic hair and liver preparations. Its Sanskrit name keshraja literally means “king of hair,” and in Tamil it is known as karisalankanni. For a modern formulator or ingredient buyer, the interesting question is what the laboratory record actually shows — and where it stops.

What Is Wedelolactone?

Wedelolactone is a coumestan — a naturally fluorescent polyphenol — and it is the compound most often chosen as the analytical marker for bhringraj. It is the target because it is characteristic of Eclipta prostrata, is well suited to quantification by HPLC, and lets a supplier put a defensible number against an otherwise variable botanical. A closely related compound, demethylwedelolactone, usually accompanies it. Because wedelolactone occurs at low natural levels, the assay percentage becomes the meaningful quality differentiator between suppliers — a point we develop in our standardisation guide.

Bhringraj's Constituent Profile

Wedelolactone is only one part of a broad phytochemical mix. The whole plant and aerial parts carry several classes of actives:

Constituent classExamples
CoumestansWedelolactone, demethylwedelolactone
Triterpene saponinsEcliptasaponins / eclalbasaponins
FlavonoidsLuteolin, apigenin
AlkaloidsEcliptalbine
Phytosterolsβ-amyrin, stigmasterol
ThiophenesSulphur-containing thiophene derivatives

This is why bhringraj is often described as a full-spectrum botanical: a native 10:1 extract carries the whole matrix, while a standardised grade concentrates the wedelolactone signal.

Hair-Growth Evidence

The hair-growth story is largely preclinical. In rodent models, topical application of Eclipta prostrata extracts has been reported to increase hair-follicle counts and produce faster hair regrowth compared with untreated controls. Proposed mechanisms include an effect on the anagen (active growth) phase of the hair cycle and possible modulation of 5α-reductase, the enzyme involved in the conversion of testosterone to dihydrotestosterone.

These are promising signals, but they come mostly from animal and in-vitro work. Human clinical data are limited, so bhringraj should be positioned as a traditionally used botanical with emerging preclinical support, not as a proven treatment for hair loss.

Positioning note: keep claims honest — “traditionally used in Ayurvedic hair care,” “preclinical studies suggest,” “in animal models.” Avoid any language that implies a proven human cure or disease treatment.

Liver & Antioxidant Research

Beyond hair, bhringraj has a long traditional association with liver support, and this too has a preclinical footprint. Wedelolactone and Eclipta extracts have shown hepatoprotective activity in animal models of chemically-induced liver injury — for example, damage induced by carbon tetrachloride (CCl4). In parallel, in-vitro studies report antioxidant and anti-inflammatory activity, which is often proposed as one basis for the observed protective effects.

As with the hair data, these findings are mechanistic and preclinical. They help explain the traditional use, but they do not establish clinical outcomes in people.

What This Means for Formulators

Bhringraj sits at an interesting point: a deep traditional record plus a growing preclinical evidence base for both hair and liver applications. The practical takeaway for product developers is that batch-to-batch consistency matters. Because the active fraction is variable in nature, specifying a wedelolactone-standardised grade (by HPLC) is the most reliable way to keep formulations consistent from lot to lot.

To choose the right grade and assay method, read our HPLC vs UV standardisation guide and the bhringraj extract buyer's guide. To specify finished material, see the Bhringraj Extract product page.